Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

ClinicalTrials.gov ID: NCT02032888

Public ClinicalTrials.gov record NCT02032888. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 2:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Evaluation of Daclatasvir Plus Sofosbuvir in Treatment-naïve and Treatment-experienced Chronic Hepatitis C (Genotype 1, 2, 3, 4, 5, or 6) Subjects Coinfected With Human Immunodeficiency Virus (HIV)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study of the efficacy and safety of the combination of daclatasvir and sofosbuvir in the treatment of hepatitis C virus and HIV coinfection.

Study identification

NCT ID
NCT02032888
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
238 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2014 (Type not available)
Primary completion
Oct 2014 (Actual)
Completion
Jan 2015 (Actual)
Last update posted
Oct 27, 2015

2014 – 2015

United States locations

U.S. sites
37
U.S. states
21
U.S. cities
30
Facility City State ZIP Site status
University Of Alabama At Birmingham Birmingham Alabama 35294 —
Pacific Oaks Medical Group Beverly Hills California 90211 —
Va Long Beach Healthcare System Long Beach California 90822 —
Peter J Ruane Md Inc Los Angeles California 90036 —
Anthony M. Mills Md Inc Los Angeles California 90069 —
Jeffrey Goodman Special Care Clinic Los Angeles California 90232 —
Ucsd Antiviral Research Center (Avrc) San Diego California 92103 —
Precision Research Institute, Llc San Diego California 92114 —
University Of California San Francisco San Francisco California 94110 —
University Of Colorado Aurora Colorado 80045 —
Whitman Walker Health Washington D.C. District of Columbia 20009 —
Medstar Washington Hospital Center Washington D.C. District of Columbia 20010 —
Capital Medical Associates Washington D.C. District of Columbia 20036 —
Midway Immunology And Research Center Ft. Pierce Florida 34982 —
University Of Miami Schiff Center For Liver Diseases Miami Florida 33136 —
Orlando Immunology Center Orlando Florida 32803 —
Infect. Disease Specialists Decatur Georgia 30033 —
Indiana University Health - University Hospital Indianapolis Indiana 46202 —
Digestive Disease Associates, P.A. Baltimore Maryland 21229 —
Johns Hopkins University Lutherville Maryland 21093 —
Henry Ford Health System Detroit Michigan 48202 —
Washington University School Of Medicine St Louis Missouri 63110 —
Southwest Care Center Sante Fe New Mexico 87505 —
Binghamton Gastroenterology Associates Binghamton New York 13903 —
Icahn School Of Medicine At Mount Sinai New York New York 10029 —
University Of Cincinnati Cincinnati Ohio 45267 —
Healthcare Research Consultants Tulsa Oklahoma 74135 —
Oregon Health Science Univ Portland Oregon 97239 —
Lehigh Valley Health Network Allentown Pennsylvania 18102 —
University Gastroenterology Providence Rhode Island 02905 —
The Miriam Hospital Providence Rhode Island 02906 —
Tarrant County Inf Dis Assoc Fort Worth Texas 76104 —
Cure C Consortium Houston Texas 77004 —
University Of Texas Health Science Center At Houston Houston Texas 77030 —
Clinical Research Centers Of America Murray Utah 84123 —
Mcguire D V A M C Richmond Virginia 23249 —
Harborview Medical Center Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02032888, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 27, 2015 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02032888 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →